The world of investing has undergone a significant transformation in recent years, thanks to the advent of online trading platforms that have made investing accessible to ordinary people. In Pakistan, these platforms have gained popularity, with a low minimum deposit of just USD 10 making it easier for anyone to start trading.
One popular asset that investors are eyeing is Pfizer, the American pharmaceutical corporation that has been in the news throughout the pandemic for its development of a highly effective COVID-19 vaccine in partnership with BioNTech. But Pfizer's history stretches back much further than the current pandemic.
Founded in 1849 by Charles Pfizer and Charles Ehrhardt in Brooklyn, Pfizer began as a small laboratory producing a cure for parasites. Over time, the company grew, and by the early 20th century, it was one of the leaders in the pharmaceutical industry in the United States. During World War II, Pfizer played a crucial role in producing antibiotics and other medicines for the front lines.
In the late 20th century, Pfizer continued to expand through a series of mergers and acquisitions, culminating in the purchase of biotech company Wyeth. This move allowed Pfizer to expand its research capabilities and develop new drugs to fight a variety of diseases.
Today, Pfizer's shares are highly sought after due to the company's strong scientific base and its track record of developing and registering new drugs. In particular, the company's work on rare and untreatable diseases has garnered attention from investors.
But it is the company's partnership with BioNTech to develop a COVID-19 vaccine that has propelled Pfizer's stock price to new heights. The vaccine has been highly effective in clinical trials, and has been approved for emergency use in countries around the world. As a result, Pfizer's stock price has risen several times over, making it an attractive investment opportunity for those looking to capitalize on the current market trends.
Overall, Pfizer's long history of innovation and research, combined with its recent success in developing a COVID-19 vaccine, make it a compelling investment option for those looking to enter the market. However, as with any investment, it is important to do your research and make informed decisions based on reliable sources of information.